Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1967 1
1968 1
1974 1
1977 5
1978 2
1980 2
1981 3
1982 1
1983 2
1984 1
1985 2
1986 2
1987 4
1988 8
1989 9
1990 3
1991 10
1992 6
1993 9
1994 8
1995 9
1996 8
1997 8
1998 7
1999 4
2000 5
2001 9
2002 15
2003 17
2004 19
2005 27
2006 21
2007 30
2008 31
2009 43
2010 45
2011 46
2012 42
2013 51
2014 39
2015 43
2016 57
2017 69
2018 53
2019 64
2020 74
2021 69
2022 56
2023 58
2024 77
2025 67

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,117 results

Results by year

Filters applied: . Clear all
Page 1
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
Gadgeel S, Rodríguez-Abreu D, Speranza G, Esteban E, Felip E, Dómine M, Hui R, Hochmair MJ, Clingan P, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Garon EB, Novello S, Rubio-Viqueira B, Boyer M, Kurata T, Gray JE, Yang J, Bas T, Pietanza MC, Garassino MC. Gadgeel S, et al. Among authors: cheng sy. J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9. J Clin Oncol. 2020. PMID: 32150489 Free article. Clinical Trial.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Among authors: cheng sy. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Autophagy and Hallmarks of Cancer.
Huang T, Song X, Yang Y, Wan X, Alvarez AA, Sastry N, Feng H, Hu B, Cheng SY. Huang T, et al. Among authors: cheng sy. Crit Rev Oncog. 2018;23(5-6):247-267. doi: 10.1615/CritRevOncog.2018027913. Crit Rev Oncog. 2018. PMID: 30311559 Free PMC article. Review.
Editorial: Translational Research in Thyroid Cancer.
Vasko V, Kebebew E, Cheng SY, Jensen KE. Vasko V, et al. Among authors: cheng sy. Front Endocrinol (Lausanne). 2020 Apr 15;11:224. doi: 10.3389/fendo.2020.00224. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32351455 Free PMC article. No abstract available.
1,117 results